Related Experiment Video
Updated: Jul 9, 2025
Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Prognostic Impact of the UMIPIC Program in the Follow Up in Patients with Heart Failure and Cardiorenal Syndrome
Manuel Méndez-Bailón1, Noel Lorenzo-Villalba2, Álvaro González-Franco3
1Internal Medicine Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clinico San Carlos (IdISSC), Universidad Complutense, 28040 Madrid, Spain.
Insights
The UMIPIC program significantly reduced hospital admissions and mortality for heart failure (HF) and cardiorenal syndrome (CRS) patients. This specialized multidisciplinary care model offers improved outcomes for high-risk individuals.
Area of Science:
- Cardiology
- Nephrology
- Healthcare Management
Background:
- Heart failure (HF) and cardiorenal syndrome (CRS) patients face high risks of hospitalization and mortality due to complex health issues.
- Specialized multidisciplinary care is crucial for managing these vulnerable patient populations.
- The UMIPIC program offers expert follow-up care for HF patients.
Purpose of the Study:
- To evaluate the effectiveness of the UMIPIC multidisciplinary care model.
- To assess the impact of UMIPIC on hospital admissions and mortality rates in HF and CRS patients.
Main Methods:
- Analysis of 3255 patient records from the RICA registry with HF and CRS types 2 and 4.
- Comparison between 1205 patients in the UMIPIC program and 2050 patients under standard care.
- Propensity score matching to ensure group comparability, with a one-year follow-up period.
Main Results:
- UMIPIC patients had significantly lower HF readmissions (20% vs. 32%, HR=0.48, p<0.001).
- UMIPIC group showed reduced mortality rates (24% vs. 36%, HR=0.64, p<0.001).
- Total hospital admissions were also lower in the UMIPIC group (36% vs. 47%, HR=0.58, p<0.001).
Conclusions:
- The UMIPIC program demonstrates significant success in reducing hospital admissions and mortality.
- Holistic and continuous care within the UMIPIC model improves outcomes for HF and CRS patients.
- UMIPIC represents an effective strategy for managing complex cardiovascular and renal conditions.
Background:
Individuals suffering from heart failure (HF) and cardiorenal syndrome (CRS) represent a special group of patients considering their age, multiple health issues, and treatment challenges. These factors make them more susceptible to frequent hospital stays and a higher mortality rate. UMIPIC is a multidisciplinary care model program for patients with heart failure follow up provided by internists and nurses who are experts in this entity. Our study delved into the effectiveness of this specialized care program (UMIPIC) in mitigating these risks for HF and CRS patients.
Methods:
We analyzed the medical records of 3255 patients diagnosed with HF and CRS types 2 and 4, sourced from the RICA registry. These patients were divided into two distinct groups: those enrolled in the UMIPIC program (1205 patients) and those under standard care (2050 patients). Using propensity score matching, we ensured that both groups were comparable. The study focused on tracking hospital admissions and mortality rates for one year after an HF-related hospital stay.
Results:
Patients in the UMIPIC group experienced fewer hospital readmissions due to HF compared to their counterparts (20% vs. 32%; Hazard Ratio [HR] = 0.48; 95% Confidence Interval [95% CI]: 0.40-0.57; p < 0.001). They also showed a lower mortality rate (24% vs. 36%; HR = 0.64; 95% CI: 0.54-0.75; p < 0.001). Furthermore, the UMIPIC group had fewer total hospital admissions (36% vs. 47%; HR = 0.58; 95% CI: 0.51-0.66; p < 0.001).
Conclusions:
The UMIPIC program, centered on holistic and ongoing care, effectively reduces both hospital admissions and mortality rates for HF and CRS patients after a one-year follow-up period.
